CTC Bio Inc banner
C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 3 945 KRW 0.13% Market Closed
Market Cap: ₩95.4B

Balance Sheet

Balance Sheet Decomposition
CTC Bio Inc

Balance Sheet
CTC Bio Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
722
842
250
262
1 731
3 075
600
335
9 854
2 898
4 336
11 582
5 211
10 371
2 388
5 234
6 532
4 626
15 270
12 174
42
0
24 629
19 171
Cash
0
0
0
0
0
0
0
0
0
0
0
0
29
425
314
230
345
475
40
37
42
0
24 629
19 171
Cash Equivalents
722
842
250
262
1 731
3 075
600
335
9 854
2 898
4 336
11 582
5 182
9 946
2 074
5 004
6 187
4 151
15 230
12 137
0
0
0
0
Short-Term Investments
382
825
1 448
654
7 606
2 880
2 654
1 121
8 561
3 025
802
3 190
25 726
3 042
2 151
1 686
2 629
9 870
1 395
2 502
280
398
50
0
Total Receivables
4 097
4 592
6 537
9 072
11 199
11 425
13 057
17 453
21 476
23 442
25 981
36 870
38 944
34 518
35 903
35 137
29 521
31 964
36 052
29 087
31 963
27 811
24 824
21 865
Accounts Receivables
3 706
4 105
4 421
7 411
10 100
10 271
12 819
17 033
19 541
20 601
24 853
35 618
37 550
32 619
35 174
33 986
28 016
30 505
32 384
28 946
30 564
26 948
24 162
20 089
Other Receivables
391
487
2 116
1 661
1 099
1 154
238
420
1 935
2 841
1 128
1 252
1 394
1 899
729
1 151
1 505
1 459
3 668
141
1 399
863
662
1 776
Inventory
1 653
2 162
3 167
3 831
5 530
4 942
7 293
11 078
14 857
15 983
21 263
28 222
26 895
26 476
28 772
29 186
32 288
30 858
28 660
30 147
29 664
35 891
32 776
30 685
Other Current Assets
901
1 335
2 701
484
321
301
725
1 275
856
614
727
1 516
1 286
2 479
3 462
2 315
1 016
1 284
6 159
1 084
1 372
1 783
1 839
1 818
Total Current Assets
7 754
9 756
14 103
14 303
26 387
22 623
24 330
31 262
55 604
45 962
53 108
81 380
98 062
76 885
72 677
73 560
71 986
78 603
87 536
74 992
70 694
89 836
84 119
73 539
PP&E Net
1 542
3 478
9 760
10 783
10 036
12 403
14 000
14 078
17 849
19 706
25 487
29 725
33 547
66 290
86 788
92 013
91 445
88 438
82 309
80 305
78 965
74 992
62 081
60 895
PP&E Gross
1 542
3 478
9 760
10 783
10 036
12 403
14 000
14 078
17 849
19 706
25 487
29 725
33 547
66 290
86 788
92 013
91 445
88 438
82 309
80 305
78 965
74 992
62 081
60 895
Accumulated Depreciation
810
712
1 086
1 888
2 798
3 575
4 475
5 703
6 573
7 887
9 313
10 715
11 921
12 932
15 733
17 273
21 249
25 656
30 403
34 350
38 832
46 360
58 656
62 151
Intangible Assets
337
1 083
1 674
2 199
1 604
2 340
2 578
2 924
2 908
3 435
3 005
2 826
2 808
3 002
3 375
3 971
5 189
5 783
7 603
12 160
11 895
11 794
11 264
9 968
Goodwill
0
0
0
0
0
0
300
240
180
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
126
58
0
238
0
4
24
88
92
208
90
20
9
5
573
72
0
0
1
2
3
0
0
Long-Term Investments
592
1 353
1 444
1 946
2 846
2 368
815
2 038
4 904
7 920
10 651
10 253
14 665
14 160
28 876
16 819
20 846
17 912
8 361
9 083
5 988
3 569
1 124
1 516
Other Long-Term Assets
383
769
1 246
1 148
1 277
1 010
1 396
1 303
596
1 112
876
1 090
1 374
1 776
1 893
1 739
2 263
951
690
632
683
6 133
7 274
7 771
Other Assets
0
0
0
0
0
0
300
240
180
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
10 608
N/A
16 564
+56%
28 286
+71%
30 378
+7%
42 387
+40%
40 745
-4%
43 423
+7%
51 869
+19%
82 128
+58%
78 227
-5%
93 335
+19%
125 364
+34%
150 476
+20%
162 123
+8%
193 614
+19%
188 675
-3%
191 800
+2%
191 687
0%
186 498
-3%
177 172
-5%
168 226
-5%
186 326
+11%
165 862
-11%
153 688
-7%
Liabilities
Accounts Payable
958
462
716
602
761
663
983
895
4 092
3 693
4 586
5 508
7 371
6 315
6 789
8 995
10 303
8 113
6 489
6 235
6 721
4 775
6 644
6 315
Accrued Liabilities
145
217
356
315
295
414
688
717
1 178
1 630
1 495
2 480
1 804
2 369
2 024
2 539
3 877
3 840
3 842
4 638
6 051
9 940
9 670
19 866
Short-Term Debt
1 352
909
5 986
4 091
5 241
2 111
4 217
13 335
12 599
19 419
20 636
41 109
36 165
43 277
50 606
57 256
46 070
43 759
37 054
32 053
25 886
30 934
29 012
27 550
Current Portion of Long-Term Debt
0
0
0
0
1 675
390
2 946
1 147
19 913
12 147
11 197
480
1 226
3 000
4 360
4 777
3 483
3 038
31 295
14 831
13 305
13 038
13 506
5 576
Other Current Liabilities
245
948
915
566
602
1 607
667
552
1 094
728
1 419
2 803
841
4 086
5 680
5 173
6 789
6 969
8 658
4 741
8 194
15 972
15 483
6 879
Total Current Liabilities
2 700
2 536
7 974
5 575
8 574
5 186
9 501
16 647
38 877
37 616
39 332
52 380
47 407
59 047
69 459
78 740
70 522
65 719
87 337
62 498
60 156
74 658
74 316
66 186
Long-Term Debt
0
0
3 121
4 855
2 709
4 115
1 341
2 537
2 000
0
7 056
7 304
6 806
10 310
17 283
14 007
40 695
31 782
11 813
27 916
10 251
6 783
3 776
3 518
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
540
883
261
2 867
605
43
313
803
793
793
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
33
20
61
36
48
28
29
95
94
5 352
2 845
5 088
0
0
0
Other Liabilities
322
461
2 278
1 915
466
749
1 004
1 148
1 457
1 809
2 128
2 740
3 154
7 014
4 836
4 400
6 461
6 907
6 454
6 804
6 924
10 982
12 325
14 364
Total Liabilities
3 022
N/A
2 996
-1%
13 373
+346%
12 345
-8%
11 749
-5%
10 050
-14%
11 846
+18%
20 332
+72%
42 333
+108%
39 458
-7%
48 536
+23%
63 025
+30%
58 286
-8%
76 681
+32%
94 474
+23%
97 781
+4%
117 817
+20%
104 815
-11%
111 759
+7%
100 856
-10%
83 213
-17%
92 423
+11%
90 417
-2%
84 068
-7%
Equity
Common Stock
1 012
1 952
1 952
2 552
4 076
4 076
4 076
4 076
4 176
4 176
6 156
7 121
8 713
8 713
8 713
8 738
8 788
9 655
9 655
10 523
11 812
12 091
12 091
12 091
Retained Earnings
4 926
6 616
7 140
8 298
9 577
10 349
11 170
10 577
12 803
16 001
14 999
23 018
23 878
19 861
22 223
20 207
1 597
8 096
16 383
35 192
39 107
33 474
49 284
55 388
Additional Paid In Capital
1 649
5 001
4 997
6 357
16 986
17 256
17 318
17 359
18 888
19 886
21 597
29 548
58 604
57 733
57 733
58 228
59 363
80 129
82 958
102 260
115 702
119 839
119 839
119 839
Unrealized Security Profit/Loss
0
0
1
1
2
1
1
1
2 929
542
2 008
2 674
4 108
2 971
14 282
0
11 272
9 091
2 329
2 586
468
714
3 399
3 129
Treasury Stock
0
2
2
2
2
987
987
390
2
1 876
6
6
3 118
4 887
4 887
4 887
4 887
4 887
4 887
4 887
4 887
4 887
4 887
4 887
Other Equity
0
0
827
827
0
0
0
84
1 001
42
46
16
5
1 051
1 075
8 608
1 044
979
1 067
1 025
1 025
1 049
1 086
1 095
Total Equity
7 587
N/A
13 568
+79%
14 913
+10%
18 032
+21%
30 639
+70%
30 695
+0%
31 577
+3%
31 537
0%
39 795
+26%
38 770
-3%
44 799
+16%
62 339
+39%
92 190
+48%
85 442
-7%
99 140
+16%
90 894
-8%
73 982
-19%
86 872
+17%
74 739
-14%
76 316
+2%
85 013
+11%
93 903
+10%
75 444
-20%
69 620
-8%
Total Liabilities & Equity
10 608
N/A
16 564
+56%
28 286
+71%
30 378
+7%
42 387
+40%
40 745
-4%
43 423
+7%
51 869
+19%
82 128
+58%
78 227
-5%
93 335
+19%
125 364
+34%
150 476
+20%
162 123
+8%
193 614
+19%
188 675
-3%
191 800
+2%
191 687
0%
186 498
-3%
177 172
-5%
168 226
-5%
186 326
+11%
165 862
-11%
153 688
-7%
Shares Outstanding
Common Shares Outstanding
7
9
9
9
13
13
13
13
13
13
14
16
17
17
17
17
17
19
19
21
23
24
24
24
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett